(AOF) – Affluent Medical announces cash flow of 6.54 million euros as of June 30, 2023, compared to 3.38 million a year ago, which allows it to extend its horizon “until February 2024” after fundraising in March. The medtech company specializing in the international development and industrialization of medical prostheses recorded a net loss of 7.98 million euros in the first half compared to 8.19 million a year ago. Affluent Medical is examining the best financing options to support the next stages of its development.
The company plans to carry out a capital increase in the coming months aimed at financing ongoing clinical programs, and which could benefit from the support of its key shareholders.
© 2023 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
